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Abstract
Background: Studies integrating transcriptomic data with proteomic data can illuminate the proteome more
clearly than either separately. Integromic studies can deepen understanding of the dynamic complex regulatory
relationship between the transcriptome and the proteome. Integrating these data dictates a reliable mapping
between the identifier nomenclature resultant from the two high-throughput platforms. However, this kind of
analysis is well known to be hampered by lack of standardization of identifier nomenclature among proteins,
genes, and microarray probe sets. Therefore data integration may also play a role in critiquing the fallible gene
identifications that both platforms emit.
Results: We compared three freely available internet-based identifier mapping resources for mapping UniProt
accessions (ACCs) to Affymetrix probesets identifications (IDs): DAVID, EnVision, and NetAffx. Liquid
chromatography-tandem mass spectrometry analyses of 91 endometrial cancer and 7 noncancer samples
generated 11,879 distinct ACCs. For each ACC, we compared the retrieval sets of probeset IDs from each mapping
resource. We confirmed a high level of discrepancy among the mapping resources. On the same samples, mRNA
expression was available. Therefore, to evaluate the quality of each ACC-to-probeset match, we calculated
proteome-transcriptome correlations, and compared the resources presuming that better mapping of identifiers
should generate a higher proportion of mapped pairs with strong inter-platform correlations. A mixture model for
the correlations fitted well and supported regression analysis, providing a window into the performance of the
mapping resources. The resources have added and dropped matches over two years, but their overall performance
has not changed.
Conclusions: The methods presented here serve to achieve concrete context-specific insight, to support well-
informed decisions in choosing an ID mapping strategy for “omic” data merging.
Background
Regulation of protein abundance is a central determi-
nant of cellular phenotype. Therefore the ability to con-
duct and interpret studies of proteome-wide alterations
in protein abundance presents tremendous promise for
biological understanding. Proteomics based on MS/MS
(tandem mass spectrometry) enables direct detections of
peptide fragments for identification and quantitation of
proteins in a proteome-wide manner. However, it has
some major handicaps, especially detection biases and
low dynamic range[1] (though techniques requiring
labeling can have great dynamic range[2]). Hybridiza-
tion-based expression microarrays represent a well-
established high-throughput technology for conducting
global measurements of mRNA transcript abundances.
However, although mRNA expression precedes protein
translation, the correlation between transcript level and
abundance of the corresponding protein product, is
often poor [3].
Thus neither transcriptomic nor proteomic studies are
perfect. However, when performed on the same samples
they are complementary [4,5]. A relevant analogy comes
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from statistics. Central to many statistical procedures
(such as empirical Bayes estimation) is the established
principle that combining two data sources with different
sources of bias and variance frequently produces greater
precision than either alone[6,7]. Genomic and proteomic
data sets have different sources of bias and variance, so
combining them may lead to a more precise view of dif-
ferential protein abundance. Consider one application,
biomarker discovery. Improving the selection of candi-
dates to validate is a worthy goal, since biomarker vali-
dation is generally elaborate and costly. If both
transcriptomic and proteomic platforms agree on a
strong differential expression between the groups of
patients to be distinguished, the attractiveness of a can-
didate strengthens. If not, the call is for caution.
The potential contributors to poor correlations are
numerous. Post-transcriptional events such as alterna-
tive splicing and microRNA regulation complicate the
link between the abundance of a specific mRNA and
production of its protein product. Thus microarray tran-
script signals may not faithfully reflect the pool of tran-
scripts available for translation. On the other hand,
proteins which degrade quickly will be underrepresented
compared to those with greater half-lives[8], so variation
in protein degradation can also reduce the correlation
between transcriptomics and proteomics. In summary,
decoupled expression at the mRNA and protein levels
might relate to post-transcription and post-translation
events; explanations might be forthcoming from studies
of microRNA-mediated regulation and protein degrada-
tion [4,9].
But the decoupling might not be biological; it might
stem from errors in the data integration. The supposed
identity of either the gene coding for the probeset’s tar-
get transcript or the detected protein may be incorrect.
The quality of a study integrating proteomic and geno-
mic data rests heavily on reliable mapping between the
identifiers of the two high-throughput platforms. Discre-
pancies between bioinformatics identifier mapping
resources are abundant. Draghici [10] has demonstrated
a variety of serious ID mapping anomalies, in which
results depend strikingly on which bioinformatics map-
ping resource is chosen. Identifier assignments for
genes, mRNA species, and proteins are managed and
the annotations curated by different bioinformatics cen-
ters. The annotation systems of the microarray probe-
sets depend on the chip manufacturer to provide
mappings to transcript identifiers, so the provenance or
motivation behind a link between an array probeset and
a mRNA species may be unclear. In addition, in mass
spectrometry the incidence of misidentification of pro-
tein accessions is not negligible, for a host of reasons,
including variations in sequence search algorithms and
tuning parameters. Therefore for consumers of these
resources, to determine with accuracy how a protein
connects with a mRNA species and thence to an micro-
array probeset can be labor-intensive and error-prone
[11].
The possibility of misidentifications is troubling in
biomarker discovery projects. When a candidate marker
appears promising, misidentification of the protein or
transcript will lead to wasted effort in initial marker
validation and/or subsequent clinical prediction studies.
With two integrated discovery platforms, on the other
hand, if a candidate appears promising in one of the
platforms but ID mapping generates a poor correlation
with the other platform, then the integration is useful by
casting suspicion on the reported identity of the
biomarker.
Despite the appeal of integrated genomic and proteo-
mic analysis, it is rarely done, and more rarely still is
the identifier mapping methodology described. But there
are pioneering examples of integrated studies. Chen [5]
studied gene expression using the Plus 2.0 Affymetrix
chip together with proteomic analysis using Isotope-
Coded Affinity Tags (ICAT) methodology. The focus
was high-risk neuroblastoma, with a small number of
clinical stage 4 samples with MYCN amplified and stage
1’s with MYCN not amplified. It was unclear how iden-
tifier mapping was performed. Another study performed
by Shankavaram et al.[4] used a protein lysate array and
the Affymetrix U133 Plus 2.0 chip to identify biomar-
kers present on the NCI-60 cancer cell panel data.
Matchminer[12] was used to obtain annotation matches.
Chen et al. 2002 [13] used integrated analysis on 76
lung adenocarcinoma and nine non-neoplastic lung tis-
sues. The report mentions that an elevation in protein
did not always correlate with an elevated mRNA expres-
sion level. The identifier mapping resource is not men-
tioned for this study.
The motivation for our study of this issue was a tran-
scriptome-proteome integrated study comparing early
endometrial cancer with normal endometrial tissue from
cancer-free subjects[14]. Preliminary efforts quickly
revealed major anomalies in some of the identifier
matches. This result motivated a deeper investigation
into the fidelity of identifier mapping, to achieve accep-
table reliability of the linkages between the two data
sets. The starting point is the proteomic study, generat-
ing UniProt ACCs. With these ACCs we queried three
prominent bioinformatics identifier mapping resources,
to obtain corresponding Affymetrix probeset identifiers.
There will be a multitude of mapping strategies obtain-
able by connecting combinations of bioinformatics
resources, but these three are the only ones that we are
aware of providing a direct mapping query suitable for
this specific purpose. Inconsistencies encountered here
are likely emblematic of all mapping strategies. Here we
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report the extent of agreements and disagreements
among the resources’ returned results.
We also utilized the two datasets to generate correla-
tions between message expression and protein expres-
sion. Such correlations have been studied before. Yu et
al [9] provide a discussion of the kinetics of the
expected relation between mRNA expression and pro-
tein expression, together with supplemental data that
suggests that correlation values may vary according to
GO-defined functional grouping, including some groups
with negative correlations. Nie et al [15] studied mRNA-
protein correlations in Desulfovibrio vulgaris. They
found that mRNA abundance explains 20-28% of pro-
tein abundance variation, and functional category
explains 10-15% of variation in correlation. We decom-
posed the correlations into a mixture with a zero-cen-
tered component and a positive component. The
mixture distribution model sheds light on the degree to
which positive correlations exceed negative ones, allow-
ing estimation of the distribution of correlations among
correctly mapped protein-probeset pairs, without need-
ing to know at this point which specific pairs are cor-
rectly mapped and which are not. The only assumption
is that the distribution of correlations among the mis-
matched pairs is symmetric around zero. We proceeded
presuming that better identifier matching should gener-
ate a higher rate of match pairs with strong correlations
between the transcript signals and corresponding pro-
tein spectral counts. This is flawed as a “gold standard”
because of issues discussed above: pre- and post-transla-
tion events which decouple expression at the mRNA
and protein levels[4,9]. Nevertheless, large observed cor-
relations are likely to be more prevalent when the ID
mapping is done correctly, and less likely when done
incorrectly. We demonstrate that the ensemble of corre-
lations is useful for evaluating mapping services even
though any individual correlation is not.
This paper first presents summaries of the retrieval
sets from each individual resource, then presents com-
parisons between pairs of resources, and finally evaluates
the mappings based on the assay correlations. The over-
all objective is to develop and demonstrate methods that
bring a needed critical but constructive eye to integra-
tive studies.
Results
Samples and data
We obtained fresh frozen endometrial cancer tissue spe-
cimens from 91 stage I endometrial patients and seven
age-matched normal endometrial samples from post-
menopausal women. Proteomic spectral count data ana-
lyzed was the sum of four LC-MS/MS analyses from
two laboratories. The combined analyses yielded 11,879
distinct protein UniProt ACCs across all samples and
both instruments. Transcript analysis using the Affyme-
trix U133 Plus 2.0 chip provided gene expression data.
Details are in the Methods section.
Annotation systems
We restricted the focus to bioinformatics resources pro-
viding direct mappings between UniProt ACCs and
Affymetrix probeset IDs. Identifier mapping systems
examined included the Affymetrix NetAffx Analysis
Center[16]; ENFIN’s EnVision and Ensembl resources
[17]; and the DAVID resource (Database for Annotation,
Visualization, and Integrated Discovery by NIAID
[18,19]. Details of the annotation systems and our meth-
ods for accessing them are provided in the Methods sec-
tion at the end of this paper. Submitting the list of
11,879 UniProt ACCs to each resource provided puta-
tive matches to probesets on the Affymetrix U133 Plus
2.0 chip. We refer to the mapping retrievals obtained
interactively from NetAffx as NetAffx_Q or Aff_Q. We
label results from processing downloaded data files as
NetAffx_F or Aff_F. We refer to results from the EnVi-
sion query web services as EnVision_Q or EnV_Q. We
refer to results obtained programmatically from the
EnSembl GUI as EnSembl_F or EnS_F. The labels
DAVID_Q or D_Q will refer to results obtained from
the DAVID web service application programming inter-
face (API). In addition we obtained DAVID Knowledge-
base files by request from the NIAID. We label probeset
match retrievals from DAVID Knowledgebase files as
DAVID_F or D_F. In general the suffix “Q” refers to
methods using a direct query method, whether pro-
grammatic or interactive, while “F” refers to methods
using downloaded files.
Our results concentrate primarily on the “Q” query-
based retrievals; similarities and contrasts with the “F”
file-based retrievals are noted as appropriate. To evalu-
ate performance changes over time we also present ear-
lier results, obtained variously in 2008 and 2009,
labeling the earlier results as above but with the suffix
“_8“.
Distribution of the number of probesets retrieved by
each resource
Beginning with the UniProt ACCs returned by Sequest
[20] for our proteomic tandem mass spectrometry
experiment, we characterized each annotation resource
individually by the distribution of the number of corre-
sponding probeset IDs returned for each ACC. Table 1
shows the percentage of ACCs with 0, 1, 2, 3 or more
probesets found.
The proportion of ACCs returning at least one corre-
sponding probeset ID was 84.7% for DAVID_Q, 73.6%
for EnVision_Q, and 72% for Affy_Q. EnVision_Q
returned the fewest probesets, and was most likely to
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return only a single match (38.2% versus 27.1% for
DAVID_Q and 31.2% for Affy_Q).
Figure 1 shows the behavior of the large-cardinality
retrieved match sets. EnVision_Q delivers fewer matches
overall, and also a lower proportion of intermediate-
sized and large sets. NetAffx_Q delivers a few large sets.
For example, for one Uniprot ACC, A2NYU9,
NetAffx_Q returned 40 probe sets while DAVID_Q and
EnVision_Q returned only one probe set. The reasons
for these discrepancies may be diverse. From NetAffx_Q
there were 81 large (40 or larger) match sets, associated
with ten immunoglubulin heavy chain genes and one
gene coding for a zinc finger protein.
Pairwise comparisons of identifier mapping resources
We compared each pair of annotation resources by con-
structing for each UniProt ACC the intersection and set
differences between the two probeset lists mapping to
that ACC. The results across all ACCs were grouped
according to whether there were no matches in either
resource, no matches in one resource with one or more
matches in the other, two identical non-empty match
sets, one match set but not the other reporting extra
matches (containing the other match set), or extra
matches reported by each resource. The fountain plot of
Figure 2 compares NetAffx_Q and DAVID_Q in this
way. The ACC counts and proportions appear at the left
of the figure. The figure is constructed by stacking
Table 1 Distribution of the number of probesets retrieved for each UniProt ACC, by bioinformatics resource.
# Affymetrix probesets returned
0 1 2 3 >3 max #probesets returned total # probesets returned
2010
DAVID_Q 15% 27% 21% 14% 22% 34 28077
EnVision_Q 26% 38% 21% 9% 5% 11 15650
NetAffx Q 18% 31% 23% 13% 15% 48 23441
2008-9
D Q_8 19% 31% 22% 13% 15% 18 22608
EnV_Q_8 23% 41% 23% 9% 4% 15 15916
Aff Q_8 29% 32% 19% 10% 10% 53 19256
# probesets matching to primary ID "Uniprot"
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Figure 1 Distribution of the number of probesets retrieved for
each UniProt ACC. Complementary empirical cumulative
distribution functions, plotted on a vertical log scale to emphasize
differences.
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C
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NetAffx_Q                                     DAVID_Q
in neither
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in left only
497 (4.2%)
same list
6240 (52.5%)
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2503 (21.1%)
excess left
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excess both
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Figure 2 Fountain plot comparing retrievals from NetAffx_Q
and DAVID_Q. Horizontal axis: For each UniProt ACC, the number
of probesets retrieved from NetAffx _Q (left of zero) and DAVID _Q
(right of zero). Vertical axis: Each horizontal slice is one ACC
(11,879 slices are stacked). ACCs were categorized, and the probeset
counts for each ACC graphed by category, sorted within category
by intersection size, then by total size. Category definition
example: “excess left” is the set of ACCs such that both probeset
retrievals were non-empty, and {probesets retrieved by NetAffx _Q}
is a strict subset of {probesets retrieved by DAVID_Q}.
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11,879 horizontal lines; each horizontal line is one ACC.
It therefore shows the classification and probeset retrie-
val size, for each of the 11,879 UniProt ACCs, by cate-
gory. Within category the results are sorted vertically by
the size of the intersection, followed by the sum of the
two retrieval set sizes (length of each horizontal line).
The extent of the disagreements among resources is
not insignificant. NetAffx_Q and DAVID_Q returned
identical non-empty answers for 52.5% of the ACCs
(For 10.8%, no probesets were found by either
resource.). Figures 3 and 4 show less agreement between
EnVision_Q and either NetAffx_Q or DAVID_Q; less
than half of the ACCs. returned identical answers.
Furthermore, each application processed a substantial
number of ACCs by returning 1, 2, and occasionally
many more probesets when the other two resources
produced no matches. This result is exemplified by the
horizontal extent of the red and blue portions of the
lines in Figures 2, 3, and 4.
In the past two years, the proportion of ACCs
matched to identical non-empty lists has increased
somewhat for NetAffx and DAVID (from 39% to 52%)
and for NetAffx and EnVision (from 31% to 45%), but
decreased slightly for DAVID and EnVision (from 39%
to 36.5%). For NetAffx, the number of ACCs with at
least one match not previously present is 1899, and the
number of ACCs previously present but no longer
matching is 504; the proportion of ACCs with identical
non-empty NetAffx lists between 2008 and 2010 is 46%
(5529/11879).
Contrasts between online query and file download ser-
vices were of interest. Comparing DAVID_Q with
DAVID_F (Figure 5), there are respectively 2.6% and
4.6% excess matches, as well as 5% and 9.9% additional
(in excess of up to 19) matches. In contrast, NetAffx Q
and F yield exactly the same match sets; however, this
perfect agreement may be a quirk of timing; previously
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Figure 3 Fountain plot comparing web interfaces: NetAffx_Q
vs EnVision_Q.
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Figure 4 Fountain plot comparing web interfaces: DAVID_Q vs
EnVision_Q.
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Figure 5 Fountain plot comparing DAVID file-based to query-
based ID mappings.
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we have found them to differ. EnV_Q and EnS_F dif-
fered by only two UniProt ACCs.
From personal correspondence with the NetAffx and
DAVID resource teams we learned that the tradeoffs
between the speed and timeliness of access vs. reliability
differ considerably between the resources. From the
developers of DAVID, it follows that the files available
on request are more accurate and more current than
the DAVID web query service. On the other hand,
obtaining the DAVID file data at the moment cannot be
fully automated, since it requires sending a request to
the DAVID team and a wait for the provision of a tem-
porary download URL. Choosing the online query to the
DAVID database over the file download would be pre-
ferable when the wait is not acceptable. In contrast,
access to the Affymetrix files is instant. However, from
discussions with an Affymetrix representative, we
learned that the results of a NetAffx query gradually
evolve with limited curation between releases of the
Affymetrix annotation file, which is fully manually
curated and released roughly quarterly. Software tools
provided by Affymetrix generally use the annotation
files, not live web queries. Due to the timing of our
recent accesses, the two recent retrievals were identical.
Mapping all probesets to ACCs
So far our results utilize ACCs provided by Sequest
database in analysis of a particular set of 98 samples, as
inputs into mapping resources, representing an archety-
pal use case for ID mapping. Reversing the direction of
the mapping, one can also utilize all of the probeset IDs
on a microarray as inputs, to characterize all ACCs that
would be mapped, independent of any particular proteo-
mic experiment. With the U133 Plus 2.0 array, the total
numbers of ACCs retrieved are seen in Table 2.
DAVID_F returns ACCs for the human ALU probeset
affx-hum_alu_at (5165). The other occasions of very
high counts are probesets that map to MHC genes.
The large discrepancy for DAVID_Q appears related
to its higher conformity to SwissProt; 74% of the ACCs
returned by DAVID_Q are in SwissProt, versus 23.5%
for Aff_Q and 25.4% for EnVision_Q. In comparison, of
the 11879 ACCs originally returned by Sequest for the
MS/MS experiment, 80.0% are in SwissProt. Among
those, the subsets mapping to at least one probeset
match by DAVID_Q, Aff_Q and EnV_Q are all primar-
ily in SwissProt (89.7%, 86.3%, and 92.% respectively).
Thus, the three resources are much more similar on a
“real-world” set of ACCs from an experiment than one
would expect from the comprehensive probeset-to-ACC
maps of Tables 3 and 4.
Annexin 2: Example of variation of transcriptome-
proteome correlations for individual proteins
To study mappings for individual proteins, we utilized
the MS/MS and U133 Plus 2.0 microarray data sets
described above. For each match of an ACC to a probe-
set ID, we merged the corresponding subsets of MS/MS
and microarray data by subject ID.
We consider one protein that appears to be elevated
in abundance in endometrial cancer relative to normal
tissue, annexin 2 (UniProt ACC = P07355). Retrievals
are shown in Table 5.
Figures 6 and 7 show merged data scatterplots for the
two probesets with the best and the worst correlation.
(The other probesets are strongly correlated with the
ANXA2 spectral counts, and with 213503_x_at. One
match, 211241_at, is new; it was not a match in
DAVID_Q_8, EnV_8 or NetAffx_8. It has moderate corre-
lations with the other probesets except 1568126_at. ) The
presence of strong correlations between protein spectral
counts and most of the probesets reinforces confidence in
the correct identification of the protein, and in the validity
of the cancer-associated differential expression.
The presence of one poor correlation does not lessen
that confidence. This example highlights the fact that a
poor correlation does not necessarily mean that the
mRNA and protein levels are truly biologically
decoupled. The cause of the poor correlation may be an
Table 2 UniProt ACCs retrieved by mapping all probesets on U133 Plus 2.0
# ACCs retrieved
0 1 2 3 >3 max # ACCs returned total # ACCs returned
2010
DAVID_F 15% 8% 11% 13% 54% 5165 293199
DAVID_Q 16% 4% 8% 12% 60% 1657 303145
EnVision_Q 41% 14% 12% 10% 23% 2388 140699
Affy_Q 26% 14% 13% 11% 36% 2185 210944
Table 3 Total numbers of ACCs returned for the U133
Plus 2.0 array.
Union Intersection Aff_Q EnV_Q D_Q D_Q only not in D_Q
140752 37989 81306 73247 97063 54283 30095
(100%) ( 27%) ( 58%) ( 52%) ( 69%) ( 39%) ( 21%)
Of 140752 ACCs returned for U133 plus 2.0 by any of DAVID_Q, EnVision_Q or
Affy_Q (”Union“), only 37989 were returned by all three (”Intersection“). A large
proportion (39%) were returned only by DAVID.
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incorrect mapping or a probe-specific assay anomaly. In
the case of 1568126_at, further investigation yields an
explanation: the NetAffx annotation grade for
1568126_at is “E”, indicating mapping only to an
expressed sequence tag. Note that the probeset ID
“_x_at” quality tag, which indicates caution because
some probes hit transcripts from different genes, does
not provide guidance; in fact it corresponds to the best
correlations. (Affymetrix documentation affirms that the
ID assignment at the time of array design is necessarily
permanent and reflects the limited knowledge at that
time). Analysis of the sequences of the probeset target
and individual probes is warranted, and under way, but
beyond the scope of this study.
Evaluation of mapping correctness by correlation analysis
To assess the quality of the identifier matches, we per-
formed merges as described in the previous section for
every UniProt-probeset pair obtained from one of the
mapping strategies. Each corresponding pair of protein
spectral counts with microarray expression signals
yielded a Spearman correlation. The rationale for exam-
ining the entire collection of correlations is as follows.
High correlations would be likely, though not guaran-
teed, to indicate a correct ID match. Negative correla-
tions or correlations plausibly generated by chance
might indicate any of several possibilities: (a) the ID
match could be incorrect; (b) any of several biological
phenomena could cause message expression to fail to
manifest proportionately in protein abundance; and/or
(c) measurement error variance and bias could mask a
true biological correlation. With these limitations in
Table 4 For each service, the collection of probesets with
at least one mapped ACC.
Service returns at least one
mapped ACC
#Probesets
Affy_Q DAVID_Q EnV_Q Any ACC At least one
SwissProt
No No No 7256 (13%) 8499 (16%)
✓ No No 898 (2%) 533 (1%)
No ✓ No 6593 (12%) 6881 (13%)
✓ ✓ No 7710 (14%) 8940 (16%)
No No ✓ 174 (0%) 134 (0%)
✓ No ✓ 444 (1%) 340 (1%)
No ✓ ✓ 433 (1%) 352 (1%)
✓ ✓ ✓ 31167 (57%) 28996 (53%)
TOTAL 54675 (100%) 54675 (100%)
Counts are for each “Venn diagram” subset of services indicated in columns 1-
3. For example, 13% of probesets return no ACC from any service; 16% return
no Swissprots. Only 57% of probesets have at least one ACC returned by all
three services. As was seen in the “0” column of Table 2, DAVID returns
answers for 85% of probesets, 74% for NetAffx, and 59% for EnVision. 80% of
ACCs are SwissProt ACCs.
Table 5 Probeset retrievals for annexin A2, and Spearman correlations with annexin A2 spectral counts.
Probeset 1568126_at 201590_x_at 210427_x_at 213503_x_at 210876_at 211241_at
DAVID Q ✓ ✓ ✓ ✓ ✓ ✓
EnVision_Q ✓ ✓ ✓
NetAffx Q ✓ ✓ ✓ ✓
Correlation w/spectral count 0.176 0.532 0.531 0.557 0.321 0.305
Pseudogene1 ✓ ✓
Annotation Grade1 E A A A A A
Exonic good match2 0 4 4 3 11 6
Exonic poor match2 11 1 1 1 0 4
Intronic2 0 0 0 0 0 1
Exonic Cross Hybridized2 0 6 6 7 0 0
1 From NetAffx web site 2 From Plandbaffy [21]
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mind, the collection of correlations was used to evaluate
the performance of each system to generate correct
matches. This analysis includes only the 480 ACCs with
at least an average of 0.5 MS/MS spectral events per
sample.
Each ACC-probeset match is classified according to
the set of annotation resources which returned the
match. Figure 8 shows the distributions of these correla-
tions, grouped by this classification. (The seven groups
are mutually exclusive.) From the distributions seen in
this figure, one confirms the widely reported fact that
protein expression and mRNA expression often do not
correlate strongly. However, there are differences among
the 7 match groups. The nonparametric smooth density
estimates of Figure 9 motivate the mixture characteriza-
tion of the next section. The mixture model will accent-
uate the meaningful inter-group differences, which are
between large positive correlations and all other
correlations.
Evaluation of mapping correctness by mixture modeling
The totality of observed Spearman correlations for all ID
pairings were fitted to a two-component mixture distri-
bution, where one density component was centered very
near zero and the other had a positive mean. The pos-
terior probability of membership in the second compo-
nent was used as the target variable in regression
analyses for evaluating the ability of each system to
identify possibly correct matches. Using this posterior
probability rather than the correlation itself focuses the
effort of prediction on the part of the correlation distri-
bution of interest.
One component, centered at 0.032 with standard devia-
tion 0.124, has weight 66%. The other component, centered
at 0.260 with standard deviation 0.189, has weight 34%.
Figure 7 Scatterplot, 1568126 _at transcript signals versus
Annexin 2 spectral counts, E = endometrioid cancer, S = serous
cancer, N = normal.
Figure 8 Correlation distributions by match group. Correlations
between log(mRNA) levels and spectral counts. Box extends to the
first and third quartile, with thick horizontal line at the median. The
group “all” constitutes matches that all three resources returned (i.e.,
the intersection); “Affx only” constitutes matches returned only by
NetAffx Q; “EnV&D_Q” constitutes matches returned by EnVision_Q
and DAVID Q but not by NetAffx_Q; etcetera.
Figure 9 Estimated correlation distributions, nonparametric.
Nonparametric smooth density estimates for selected ID pair
subsets; for example, “DQ” labels the density estimate for the union
of these disjoint groups from Figure 8: “D_Q only”, “Affx &D_Q”,
“D_Q&EnV”, and “all”. The label “union” is all pairs regardless of
which mapping resource was the source of the match.
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Figure 10 shows that the mixture model fits remark-
ably well. We do not claim that the correlations in rea-
lity come from a mixture distribution, though that is
possible. Even if correct, membership in the first com-
ponent may represent an incorrect match or a true bio-
logical disconnect between mRNA and protein
abundance, and membership in the second component
may or may not represent correct matches, since chance
can generate extreme values. Nevertheless, the mixture
model is extremely useful in this setting since the prob-
ability of membership in the second group, compared to
using the correlation itself, is more sensitive to large
correlations and relatively insensitive to differences
between correlations that are not among the larger
values. Therefore it makes a more useful dependent
variable for the regression analyses to follow. The box
plots of Figure 11 are similar to the box plots of Figure
8, but displaying the second component posterior prob-
abilities rather than the correlations. The differences
between match groups are considerably enhanced.
Linear regression analyses provided evaluations of the
ability of each matching application to predict a high
correlation. A linear regression models was fitted relat-
ing the presence or absence of a match in each mapping
system to the component #2 probabilities.
The coefficient estimates from this model were: 0.119
for EnVision (P < 4 × 10-10), 0.039 for DAVID (P =
0.13), and 0.038 for NetAffx (P = 0.08). So, for example,
if a match is returned by EnVision, the second compo-
nent probability increased by 12.6% (= exp(0.119)-1).
(Addition of total protein identification spectral count
to the model did not affect the results. Here the weights
were from the bootstrap analysis described in Methods.
Similar results were returned when the normal theory
weights were used.)
The results of this analysis suggest that a match in
EnVision is more predictive of a good positive proteo-
mic-genomic correlation, compared to matches provided
by NetAffx or DAVID. However, this suggestion did not
receive corroboration in head-to-head comparisons
(example: pairs returned by EnVision but not NetAffx,
compared to those returned by NetAffx but not by
EnVision). Comparing pairs of disjoint groups from Fig-
ure 10, the one clear comparison, supported by large
sample sizes, shows that a pair returned by DAVID and
NetAffx is more likely to belong to the high-correlation
cluster if it is also returned by EnVision (mean probabil-
ities: 0.407 versus 0.290, P < 2 × 10-7). (We have used
Spearman correlations throughout. Pearson correlations
yield a somewhat higher second component probability,
48% instead of 34%, but shifted to lower correlation
values within that component; overall the conclusions of
the regressions are very similar.)
Filtering the ACCs further by restricting to SwissProt
changed these results little; in fact this dropped only 3%
(5 out of 480) ACCs, and 3% (43 out of 1573) of the
Figure 10 Estimated correlation distributions, mixture model.
The correlation distribution smoothed, as a mixture. The black line
is the estimated mixture distribution; the red and green are the
estimated mixture components. For comparison, the orange line is
an nonparametric smooth density estimate. The rug ticks are
observed correlations, and the tick colors indicate group assignment
by maximum posterior probability. Correlations greater than 0.217
have Pr(mixture component #2) > 0.5, and corresponding tick are
colored green for component #2.
Figure 11 Distributions of the “large correlation component”
probability, for each match group. Transformation of Figure 8,
replacing the vertical correlation axis by the estimated probability of
belonging to the second ("large correlation”) component of the
mixture shown in green in Figure 10. Horizontal line corresponds to
a probability of 50%.
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ACC-probeset pairs. This reflects the fact that, over all
ACCs, the association between SwissProt status and total
spectral count is strong (Figure 12). SwissProt status is
also associated with stronger correlations (Figure 13).
Changes in the bioinformatics resources over time
In the past two years, there have been substantial
changes in most of the services. The following table
(table 6) shows the numbers of probeset mappings
gained, lost, and maintained.
A variety of analyses comparing added pairs to
dropped pairs, or kept pairs to dropped pairs, revealed
no evidence for NetAffx or for EnVision that the fre-
quency of high correlations is changing. For DAVID_F,
the ID pairs kept had significantly better correlations
than those dropped (P = 2 × 10-6); similarly for
DAVID_Q (P = 0.0001). However, the 267 pairs added
recently in DAVID_Q were not superior to those
dropped.
Discussion
Integrating high-throughput biological data from multi-
ple high-throughput platforms on the same set of sam-
ples will play an expanding role in basic biomedical
research. Our picture of the molecular biology of tissue
function now requires systems modeling. We would not
understand the workings of an automobile if we only
had access to a gas tank and a brake cylinder (or even
98 of each). We will be handicapped until we can pool
perspectives on each and every important interacting
molecular domain which we typically now view indivi-
dually. This kind of integration of views from high-
throughput platforms requires first a reliable mapping
between the identifier lingua franca native to each plat-
form. Bioinformatics resources to support this mapping
are ever growing in number, comprehensiveness and
sophistication. However, we have found that discrepan-
cies between annotation resources mapping identifiers
are surprisingly large. Uncritiqued erroneous mappings
will lead to wasted effort in subsequent studies whose
design and focus depended on the integrated study. On
the other hand, when an interesting candidate molecule
appears in one of the platforms, but ID mapping gener-
ates a poor correlation with the other platform, the inte-
gration can be useful by casting suspicion on the
reported identity of the promising molecule. In the
annexin 2 example, most but not all probesets mapping
to annexin 2 yield good transcriptome/proteome corre-
lations and a consistent view of differential expression.
We found that a match in EnVision predicts positive
proteomic-genomic correlations the best, DAVID less
so, and NetAffx the least. Nevertheless, as the boxplots
of Figure 8 show, many matches found in DAVID and/
or NetAffx but not in EnVision also had high correla-
tions, and many matches reported by EnVision gener-
ated low correlations. Therefore, our results do not
Figure 12 QQ plot of total spectral counts by protein.
Figure 13 QQ plot for Pearson correlations between spectral
counts and mRNA signal,; restricting to 1573 pairs discussed
above and shown in Figures 8, 9, 10, and 11.
Table 6 Changes in probeset maps from proteomic
experiment to U133 Plus 2.0.
DAVID_Q DAVID_F NetAff_Q NetAff_F EnVision_Q
added 267 0 442 34 73
dropped 62 258 43 44 64
maintained 1134 1187 705 1113 814
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reduce to a clear recommendation to use one resource
and not another. In fact, typical of many decisions, the
trade-off between accepting a false match and rejecting
a true match should govern the strategy.
The example presented here gives a concrete sense of
the variability and discrepancy one can expect when
attempting to integrate multiple-platform datasets by
ID. Nevertheless, the primary value of this work is in
the methodology, which has general utility for new inte-
grative studies. The ID mapping resources studied here
are evolving, as we have described. We deliberately
restricted the focus of this study to bioinformatics
resources providing direct mappings, but beyond this
narrow scope one can conceive a multitude of indirect
multiple-step strategies, using one or more intermediate
identifiers, and possibly more than one resource[10].
Finally, new resources may well develop, providing new
alternatives for ID mapping. Researchers engaging in
integrated data analyses may well need to replicate the
kind of study presented here, to compare their own
selected mapping strategies on their own datasets.
Therefore, the question of the best approach to linking
these data will continue to be active and require
dynamic answers. Furthermore, new platforms will
expand the need for identifier mapping. Next generation
sequencing will introduce new requirements, opportu-
nities and challenges for multiple-platform data
integration.
Several R packages are available through Bioconductor
or directly from the authors (RSD), to conduct the ana-
lyses described herein on other pairs of identifier-
indexed data sets. They include DAVIDQuery, Envision-
Query, IdMappingRetrieval, and IdMappingAnalysis.
Conclusion
Identifier mapping is a key step in integrative bioinfor-
matics analysis. Evaluation of mapping services and stra-
tegies is both possible and valuable, despite the
biological and technical causes that may lessen or
destroy interplatform correlations. Integrative analysis
may contribute by casting suspicion on molecule identi-
fications. More positively, it may open doors to new
biology by directing attention to a correctly mapped but
decoupled interplatform pair of observations.
Methods
Tissue samples
Duke University Medical Center and the Gynecologic
Oncology Group provided fresh frozen endometrial can-
cer tissue specimens from 91 stage I endometrial
patients, under IRB-approved protocols at the corre-
sponding institutions. Endometrial tissue specimens har-
vested by pathologists at the time of surgery were frozen
until the time of the analysis. Hematoxylin and eosin
(H&E) stained tissue specimens were evaluated by one
of two board certified gynecologic pathologists to con-
firm the diagnosis. Seven age-matched normal endome-
trial samples from post-menopausal women comprised
the control sample set.
Proteomic spectral count data on the same samples
originated from Orbitrap and FT-ICR mass spectro-
meters. Details of the sample preparation, instrumenta-
tion, and spectral identifications are in Maxwell et al
[14]. The gene expression data were from Affymetrix
U133 Plus 2.0 microarrays. The raw data.cel and.chp
files have been submitted to GEO in a MIAME compli-
ant format (http://www.ncbi.nlm.nih.gov/geo/query/acc.
cgi?token=bhmrrwmyyqsoeba&acc=GSE17025) and will
be released July 8, 2011.
Annotation systems
The identifier mapping systems examined included the
Affymetrix NetAffx Analysis Center; ENFIN’s EnVision
and Ensembl resources; and the DAVID resource (Data-
base for Annotation, Visualization, and Integrated Dis-
covery by NIAID.
The NetAffx online resource[16], maintained by Affy-
metrix, permits the query of probe set information from
Affymetrix GeneChip microarrays. A query takes as
input a list of identifiers for genes, transcript or pro-
teins, and provides (i) information on the development
of each probe set including probe set target nucleotide
sequence; (ii) corresponding gene, transcript and protein
identifiers from public repositories; and (iii) connection
information to other Affymetrix microarray experiments.
The query provides immediate access to static informa-
tion on the probe set and current public repository
annotations. Below we refer to the mapping retrievals
obtained interactively from NetAffx as NetAffx_Q or
Aff_Q. Manually curated information is available as a
CSV file which is updated on a quarterly basis. For the
U133_Plus 2.0 chip, the file is specified as HG-
U133_Plus_2.naXX.annot, where XX represents the cur-
rent version iteration. The curation process is proprie-
tary to Affymetrix, Inc.
The European Network of Excellence (ENFIN) )[17], a
consortium for integrated systems biology, developed
the EnCore integration platform. The EnCore Knowl-
edge base connects relational data across multiple major
bioinformatics databases including genome information
(Ensembl), protein identification (PRIDE), pathway
annotation (Reactome), molecular information (INAct)
and gene Expression (ArrayExpress) to name a few. Two
EnCore web graphical user interfaces (GUIs), EnVision
and EnVision2, provide access to data for queries of lim-
ited size. EnCore also provides access to these bioinfor-
matics resources through SOAP-based query web
services with a common standard format, EnXML. Our
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study utilized the uniprot2affy service. Subsequent filter-
ing restricted results to Human U133 Plus 2.0 Affyme-
trix probesets.
Ensembl is a joint project between European Bioinfor-
matics Institute (EBI), an outstation of the European
Molecular Biology Laboratory (EMBL), and the Well-
come Trust Sanger Institute (WTSI). The goal of
Ensembl is to automatically annotate the genome, inte-
grate this annotation with other available biological data,
and make all this publicly available via the web. All
Ensembl data can be accessed programmatically using
the Perl API or through a GUI to retrieve unlimited
amounts of data through bulk file download. Our study
utilized the GUI to retrieve ID mapping data in the
form of comma-separated-value (csv) file, filtered by
species and microarray.
DAVID[11,22] is an annotation system developed by
the National Institute of Allergy and Infectious Diseases
at Frederick in conjunction with the Laboratory of
Immunopathogenesis and Bioinformatics (LIB), SAIC
Frederick. The DAVID Gene concept is defined for each
known gene as a nonredundant annotation that unifies
all functional annotation sources. The coverage of the
DAVID Knowledgebase includes gene ontology and
function, protein-protein interaction, disease association,
literature references, protein domains and families, bio-
logical pathway, and gene expression annotation systems
(12). DAVID offers a very simple DAVID Knowledge-
base Query Tool API.
Matches to the UniProt set were obtained from the
DAVID Knowledgebase using the DAVIDQuery R pack-
age available through the Bioconductor network[23].
This package utilized two functions in order to retrieve
our representative dataset: DavidQueryLoop, which com-
pletes the query in one set of input rather than multiple
submissions and AffyProbesetList, which restricts the
UniProt to Affy probeset retrievals to only the Human
U133 Plus 2.0 Affymetrix chip. In addition we obtained
DAVID Knowledgebase files by request from the NIAID.
Results obtained variously in 2008 and 2009 are
labeled as above but with the suffix “_8“.
Regression modeling
Regression weights were chosen as reciprocals of pair-
specific variances, estimated in two ways: using the nor-
mal theory expression for the variance (1-r2)/(n-3) of a
Pearson correlation coefficient estimate ρˆ, and using a
bootstrap variance estimate (R = 200 replications). The
smooth fit for the relationship between the correlation
and the bootstrap standard deviation follows the normal
theory curve well except at large values, but the indivi-
dual bootstrap estimates vary from the curve substan-
tially (Figure 14).
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